UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000019983 |
|---|---|
| Receipt number | R000023073 |
| Scientific Title | Effect of Rebamipide and Diquafosol Ophthalmic Suspension on Ocular Surface for Dry Eye After Penetrating Keratoplasty: Randomized Controlled Trials. |
| Date of disclosure of the study information | 2015/11/29 |
| Last modified on | 2015/12/05 15:31:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of Rebamipide and Diquafosol Ophthalmic Suspension on Ocular Surface for Dry Eye After Penetrating Keratoplasty: Randomized Controlled Trials.
Acronym
Ocular Surface after Penetrating Keratoplasty
Scientific Title
Effect of Rebamipide and Diquafosol Ophthalmic Suspension on Ocular Surface for Dry Eye After Penetrating Keratoplasty: Randomized Controlled Trials.
Scientific Title:Acronym
Ocular Surface after Penetrating Keratoplasty
Region
| Japan |
Condition
Condition
Dry Eyes after Penetrating Keratoplasty
Classification by specialty
| Ophthalmology | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare ocular surface between rebamipide and diquafosol ophthalmic solutions in dry eyes after penetrating keratoplasty.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Ocular surface parameters and subjective symptom before and after ophthalmic solutions
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Rebamipide Ophthalmic Suspension: 4 times a day during 4 weeks after treatment
Interventions/Control_2
Diquafosol Ophthalmic Suspension: 4 times a day during 4 weeks after treatment
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Dry eyes after penetrating keratoplasy.
Key exclusion criteria
None
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hidenaga Kobashi |
Organization
University of Kitasato School of Medicine
Division name
Department of Ophthalmology
Zip code
Address
1-15-1 Kitasato, Sagamihara, Kanagawa, 228-8555, Japan
TEL
+81-42-778-9012
himon@hotmail.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hidenaga Kobashi |
Organization
University of Kitasato School of Medicine
Division name
Department of Ophthalmology
Zip code
Address
1-15-1 Kitasato, Sagamihara, Kanagawa, 228-8555, Japan
TEL
+81-42-778-9012
Homepage URL
himon@hotmail.co.jp
Sponsor or person
Institute
University of Kitasato School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Grant-in-Aid for Young Scientists (B)
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 11 | Month | 29 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 07 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 07 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 11 | Month | 29 | Day |
Last modified on
| 2015 | Year | 12 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023073
